Colorectal cancer has long baffled scientists because, unlike most tumors, patients often do better when their cancers are packed with immune-suppressing regulatory T cells. New research finally ...
Vitamin D modulates immune responses, influencing inflammation, T-cell activation, and tumor suppression, crucial for CRC prevention and progression. Higher serum vitamin D levels are linked to ...
A research team led by Prof. GU Hongcang and ZHANG Fan from the Hefei Institutes of Physical Science, Chinese Academy of Sciences, has identified a novel long non-coding RNA (lncRNA)-driven regulatory ...
Mass General Brigham study tracks how the tumor microenvironment develops during progression, signaling an opportunity for early detection and risk prediction Colorectal cancer precursor lesions are ...
High numbers of regulatory T cells (red) — seen here interacting with antigen-presenting cells (blue) — are usually associated with poorer outcomes in cancer. A new MSK study, however, found that a ...
Immune evasion continues to limit the effectiveness of cancer immunotherapies. Among emerging regulatory molecules, transfer RNA-derived small RNAs (tsRNAs of 13-48 nucleotides), generated through ...
In a study presented at the American Association for Cancer Research's annual meeting, researchers report encouraging early results from research investigating a potential way to help some cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results